-
Mashup Score: 8Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial - 2 month(s) ago
Findings from a novel study supports the JAK inhibitor tofacitinib as a potential first-line therapy for ASUC.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
Findings from a novel study supports the JAK inhibitor #tofacitinib as a potential first-line therapy for acute severe ulcerative colitis. @RavShahMD reviews data from TACOS and gives his perspective in today's #QaziCorner issue. Read it here: https://t.co/gUTSt5lyjM https://t.co/8RHK6dhqMr